Healium Medical Named Finalist at MedTech Innovator Asia-Pacific 2024

We’re thrilled to announce that Healium Medical was selected as a finalist in the MedTech Innovator Asia-Pacific 2024 program, and had the honor of presenting on the main stage at the APACMed MedTech Forum in Singapore.

Out of hundreds of applicants across the region, Healium was chosen as one of the top innovators shaping the future of healthcare. This recognition highlights the impact and promise of our Echomplish™ Dual-Mode Ultrasound Technology—a platform designed to deliver non-contact, image-guided ablation therapy with real-time monitoring and intelligent control.

Presenting at APACMed allowed us to share our vision with a global audience of clinicians, investors, and industry leaders. We’re grateful for the opportunity to connect with such a vibrant and forward-thinking community, and we’re excited about the partnerships and momentum that are emerging from this experience.

A heartfelt thank you to MedTech Innovator and APACMed for this incredible platform—and to our team, partners, and supporters who continue to drive our mission forward.

The future of precision therapy is here—and we’re just getting started.